Understanding PharmEasy's Unlisted Share Price Variation

One of the defining features of the unlisted shares market is price fragmentation — and PharmEasy's current quotes illustrate this well. As of 22 September 2026, PharmEasy's unlisted share price isn't uniform across the market; different unlisted share dealers are quoting anywhere between ₹5.60 and ₹7.95 per share. Some are pricing closer to ₹8.5, while others are offering it in the ₹5–6 band, typically with a minimum lot size of 100 shares.

This spread isn't unusual — it's inherent to how unlisted shares trade. With no exchange to anchor prices, each dealer effectively sets their own rate based on inventory levels, demand from buyers, and the specifics of the deal size involved. As a result, prices can shift from one day to the next. Anyone planning an actual purchase or sale should treat online quotes as indicative only and get the live, confirmed price from their broker right before transferring any funds.

Because these trades happen Over-the-Counter (OTC) rather than through a regulated exchange, the reliability of the dealer becomes a critical factor alongside the price itself. This is one reason many investors prefer working with an unlisted shares dealer that has a physical office in Noida or elsewhere in Delhi-NCR — face-to-face access simplifies verification, speeds up Client Master Report (CMR) processing, and makes it easier to resolve disputes, compared to dealing with anonymous, purely digital brokers.